ERCC1 and cancer: They found the recurrence rate to be significantly lower in patients with a greater number of total variant alleles in all DNA repair genes and in NER genes, not including ERCC1 (P = 0.03), and the total number of variant alleles were significantly associated with improved cancer-specific survival in a univariate analysis.